The Latest Cardiac and Vascular News
First patient enrolled in Frontier V study evaluating enhanced fully absorbable, patch-based large-bore percutaneous closure device GALWAY, Ireland–(BUSINESS WIRE)–Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the first patient was enrolled in the Frontier V study, a European multicenter study evaluating PerQseal®+, the […]
Glass brings significant global experience in product development, clinical strategy and commercialization within the cardiovascular industry GALWAY, Ireland–(BUSINESS WIRE)–Vivasure Medical®, a company pioneering fully absorbable solutions for large hole percutaneous vessel closure, today announced Andrew Glass has assumed the role of chief executive officer. Founder and former CEO Ger Brett […]
GALWAY, Ireland–(BUSINESS WIRE)–Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the European launch of the PerQseal® closure device for large-bore transcatheter procedures. Novel transcatheter endovascular procedures, including transcatheter aortic valve replacement (TAVR), thoracic endovascular aneurysm repair (TEVAR), and endovascular abdominal aneurysm repair (EVAR), require […]
